The effect of recombinant alpha-interferon treatment on serum levels of hepatitis B virus-encoded proteins in man. (Q45830455)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	The effect of recombinant alpha-interferon treatment on serum levels of hepatitis B virus-encoded proteins in man.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3610048

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/3610048

title

The effect of recombinant alpha-interferon treatment on serum levels of hepatitis B virus-encoded proteins in man. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3610048

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/3610048

main subject

Hepatitis B virus

1 reference

based on heuristic

inferred from title

author

Guido Gerken

series ordinal

3

object named as

Gerken G

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3610048

retrieved

16 December 2017

Karl-Hermann Meyer zum Büschenfelde

series ordinal

6

object named as

Meyer zum Büschenfelde KH

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3610048

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/3610048

author name string

Hess G

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3610048

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/3610048

Gerlich W

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3610048

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/3610048

Manns M

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3610048

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/3610048

Hütteroth TH

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3610048

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/3610048

language of work or name

English

0 references

publication date

1 July 1987

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3610048

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/3610048

published in

Hepatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3610048

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/3610048

volume

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3610048

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/3610048

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3610048

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/3610048

page(s)

704-708

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3610048

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/3610048

cites work

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.1840070414

retrieved

21 January 2018

Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.1840070414

retrieved

21 January 2018

Spontaneous disappearance of viral replication and liver cell inflammation in HBsAg-positive chronic active hepatitis: results of a placebo vs. interferon trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.1840070414

retrieved

21 January 2018

Biochemical pathways in interferon-action

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.1840070414

retrieved

21 January 2018

Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.1840070414

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.1840070414

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind study of leucocyte interferon administration in chronic HBsAg-positive hepatitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.1840070414

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral and protein-inducing activities of recombinant human leukocyte interferons and their hybrids

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.1840070414

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.1840070414

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Sites that bind polymerized albumin on hepatitis B surface antigen particles: detection by radioimmunoassay

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.1840070414

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemagglutination and immunofluorescence studies on polymerized human serum albumin binding activity in chronic hepatitis B virus infection

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.1840070414

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A frameshift mutation in the pre-S region of the human hepatitis B virus genome allows production of surface antigen particles but eliminates binding to polymerized albumin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.1840070414

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/HEP.1840070414

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3610048

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/3610048

PubMed publication ID

3610048

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3610048

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/3610048

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45830455&oldid=1859319486"